OXBRIDGE RE HOLDINGS LTD (OXBR) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:OXBR • KYG6856M1069

1.0453 USD
-0.01 (-1.39%)
Last: Feb 3, 2026, 08:00 PM
Fundamental Rating

2

Taking everything into account, OXBR scores 2 out of 10 in our fundamental rating. OXBR was compared to 147 industry peers in the Insurance industry. OXBR may be in some trouble as it scores bad on both profitability and health. OXBR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • OXBR had negative earnings in the past year.
  • In the past year OXBR has reported a negative cash flow from operations.
  • In the past 5 years OXBR reported 4 times negative net income.
  • OXBR had a negative operating cash flow in each of the past 5 years.
OXBR Yearly Net Income VS EBIT VS OCF VS FCFOXBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

  • OXBR's Return On Assets of -30.03% is on the low side compared to the rest of the industry. OXBR is outperformed by 96.60% of its industry peers.
  • Looking at the Return On Equity, with a value of -46.57%, OXBR is doing worse than 90.48% of the companies in the same industry.
Industry RankSector Rank
ROA -30.03%
ROE -46.57%
ROIC N/A
ROA(3y)-55.81%
ROA(5y)-23.91%
ROE(3y)-88.98%
ROE(5y)-43.22%
ROIC(3y)N/A
ROIC(5y)N/A
OXBR Yearly ROA, ROE, ROICOXBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

  • OXBR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OXBR Yearly Profit, Operating, Gross MarginsOXBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

1

2. Health

2.1 Basic Checks

  • OXBR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • OXBR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, OXBR has more shares outstanding
  • OXBR has a worse debt/assets ratio than last year.
OXBR Yearly Shares OutstandingOXBR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
OXBR Yearly Total Debt VS Total AssetsOXBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • OXBR has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • OXBR's Debt to Equity ratio of 0.02 is amongst the best of the industry. OXBR outperforms 87.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.86%
OXBR Yearly LT Debt VS Equity VS FCFOXBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
OXBR Yearly Current Assets VS Current LiabilitesOXBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K 400K 500K

6

3. Growth

3.1 Past

  • OXBR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.00%, which is quite impressive.
  • Looking at the last year, OXBR shows a decrease in Revenue. The Revenue has decreased by -4.13% in the last year.
  • OXBR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.27% yearly.
EPS 1Y (TTM)56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.78%
Revenue 1Y (TTM)-4.13%
Revenue growth 3Y-35.49%
Revenue growth 5Y28.27%
Sales Q2Q%201.9%

3.2 Future

  • Based on estimates for the next years, OXBR will show a very strong growth in Earnings Per Share. The EPS will grow by 31.06% on average per year.
  • OXBR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 42.82% yearly.
EPS Next Y102.28%
EPS Next 2Y39.8%
EPS Next 3Y31.06%
EPS Next 5YN/A
Revenue Next Year10.64%
Revenue Next 2Y25.41%
Revenue Next 3Y42.82%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OXBR Yearly Revenue VS EstimatesOXBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M 20M
OXBR Yearly EPS VS EstimatesOXBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0 0.02 -0.02 0.04 0.06 0.08 0.1

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OXBR. In the last year negative earnings were reported.
  • Also next year OXBR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OXBR Price Earnings VS Forward Price EarningsOXBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OXBR Per share dataOXBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

  • OXBR's earnings are expected to grow with 31.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.8%
EPS Next 3Y31.06%

0

5. Dividend

5.1 Amount

  • No dividends for OXBR!.
Industry RankSector Rank
Dividend Yield 0%

OXBRIDGE RE HOLDINGS LTD

NASDAQ:OXBR (2/3/2026, 8:00:02 PM)

1.0453

-0.01 (-1.39%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-06
Earnings (Next)03-24
Inst Owners8.06%
Inst Owner Change11.26%
Ins Owners10.72%
Ins Owner Change-1.33%
Market Cap8.03M
Revenue(TTM)2.72M
Net Income(TTM)-2.66M
Analysts82.86
Price Target5.1 (387.9%)
Short Float %0.12%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-506.54%
Min EPS beat(2)-916.99%
Max EPS beat(2)-96.08%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-28.12%
Min Revenue beat(2)-40.02%
Max Revenue beat(2)-16.23%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.95
P/FCF N/A
P/OCF N/A
P/B 1.41
P/tB 1.41
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS0.35
BVpS0.74
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.03%
ROE -46.57%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-55.81%
ROA(5y)-23.91%
ROE(3y)-88.98%
ROE(5y)-43.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.86%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.09%
Cap/Sales(5y)0.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.78%
EPS Next Y102.28%
EPS Next 2Y39.8%
EPS Next 3Y31.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.13%
Revenue growth 3Y-35.49%
Revenue growth 5Y28.27%
Sales Q2Q%201.9%
Revenue Next Year10.64%
Revenue Next 2Y25.41%
Revenue Next 3Y42.82%
Revenue Next 5YN/A
EBIT growth 1Y-614.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-16.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-16.93%
OCF growth 3YN/A
OCF growth 5YN/A

OXBRIDGE RE HOLDINGS LTD / OXBR FAQ

What is the ChartMill fundamental rating of OXBRIDGE RE HOLDINGS LTD (OXBR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to OXBR.


Can you provide the valuation status for OXBRIDGE RE HOLDINGS LTD?

ChartMill assigns a valuation rating of 1 / 10 to OXBRIDGE RE HOLDINGS LTD (OXBR). This can be considered as Overvalued.


Can you provide the profitability details for OXBRIDGE RE HOLDINGS LTD?

OXBRIDGE RE HOLDINGS LTD (OXBR) has a profitability rating of 0 / 10.


Can you provide the financial health for OXBR stock?

The financial health rating of OXBRIDGE RE HOLDINGS LTD (OXBR) is 1 / 10.